Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Obi L Griffith

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Nature Communications|November 16, 2018
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancerObi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Cancer Research Communications|November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaFelicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Blood Advances|May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphomaCody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
Breast Cancer Research and Treatment|June 26, 2021
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancerFoluso O Ademuyiwa, Ina Chen, Jingqin Luo, et al.
Nature Genetics|April 5, 2020
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancerAlex H Wagner, Brian Walsh, Georgia Mayfield, et al.
Nature Genetics|January 19, 2010
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center originRyan D Morin, Nathalie A Johnson, Tesa M Severson, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Experimental Hematology|May 17, 2016
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaMalachi Griffith, Obi L Griffith, Kilannin Krysiak, et al.
Nature Cancer|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialElizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Arxiv|December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trialsKartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Nature Communications|November 16, 2018
Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancerObi L Griffith, Nicholas C Spies, Meenakshi Anurag, et al.
Cancer Research Communications|November 1, 2023
Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaFelicia Gomez, Bryan Fisk, Joshua F McMichael, et al.
Blood Advances|May 7, 2024
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphomaCody A Ramirez, Michelle Becker-Hapak, Kartik Singhal, et al.
Breast Cancer Research and Treatment|June 26, 2021
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancerFoluso O Ademuyiwa, Ina Chen, Jingqin Luo, et al.
Nature Genetics|April 5, 2020
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancerAlex H Wagner, Brian Walsh, Georgia Mayfield, et al.
Nature Genetics|January 19, 2010
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center originRyan D Morin, Nathalie A Johnson, Tesa M Severson, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Experimental Hematology|May 17, 2016
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemiaMalachi Griffith, Obi L Griffith, Kilannin Krysiak, et al.
Nature Cancer|May 12, 2026
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trialElizabeth A R Garfinkle, Renzo Perales-Linares, Ryan C Gimple, et al.
Arxiv|December 19, 2025
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trialsKartik Singhal, Evelyn Schmidt, Susanna Kiwala, et al.
Pageof 18